Guidant's CTS Buy Provides Platform For Growth In Cardiac Surgery Market
This article was originally published in The Gray Sheet
Executive Summary
Guidant's planned acquisition of minimally invasive cardiac surgery device maker CardioThoracic Systems for $313 mil. in stock provides greater access to cardiac surgeons as well as a platform for growth in the cardiac surgery market.